See the DrugPatentWatch profile for qulipta
The cost of Qulipta without insurance can vary depending on the pharmacy and any available discount programs. A 30-day supply of Qulipta (60 mg dose) may cost around $900 to $1000 [1].
What are the savings options for Qulipta?
To potentially lower the out-of-pocket cost of Qulipta, patients may be able to use discount cards or coupons. For eligible individuals, savings of up to $100 per month on a 30-day supply are advertised [1]. Information on these programs can often be found on the drug manufacturer's website.
How does Qulipta work?
Qulipta is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the activity of CGRP, a molecule that is believed to play a role in migraine headaches [2]. By inhibiting CGRP, Qulipta helps to prevent migraines [2].
When does Qulipta patent expire?
The primary patent for Qulipta, U.S. Patent No. 8,410,120, is set to expire in 2034 [3]. However, the exact date of patent expiry can be complex due to potential extensions and other patent filings [3]. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Qulipta [3].
Who makes Qulipta?
Qulipta is manufactured by AbbVie [1].
What are the common side effects of Qulipta?
Common side effects of Qulipta may include constipation, nausea, and fatigue [2].
How does Qulipta compare to other migraine prevention medications?
Qulipta belongs to a class of drugs known as CGRP inhibitors, which are a newer option for migraine prevention. Other medications for migraine prevention include older classes of drugs like beta-blockers, anticonvulsants, and antidepressants, as well as newer CGRP-targeting monoclonal antibodies administered via injection [4]. Qulipta is taken orally, differentiating it from injectable CGRP therapies [4].
Can generic versions of Qulipta be available?
Generic versions of Qulipta may become available after the expiration of its primary patents. The availability of generics depends on patent challenges and regulatory approvals [3].
Sources:
[1] https://www.qulipta.com/savings-and-support
[2] https://www.qulipta.com/migraine-medication
[3] https://drugpatentwatch.com/en/drug/qulipta
[4] https://www.mayoclinic.org/diseases-conditions/migraine-headache/in-depth/migraine-prevention/art-20046541